January 7, 2019 / 8:10 AM / 8 months ago

BRIEF-Mithra Pharmaceuticals Potential New Perimenopause Product Launch In 2023

7/1/2019(Reuters) - MITHRA PHARMACEUTICALS SA:

* MITHRA ANNOUNCED ON MONDAY POTENTIAL FOR NEW PERIMENOPAUSE PRODUCT CANDIDATE PERINESTA LAUNCH AS EARLY AS 2023

* DONESTA PHASE III E4 MONOTHERAPY PATIENT RECRUITMENT ANTICIPATED TO START IN Q3 2019 PENDING APPROVALS

* ONGOING GLOBAL PATENT FILINGS COULD PROTECT DONESTA AND PERINESTA IP ESTATE UNTIL 2039

Source text for Eikon:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below